(Reuters) -Moderna Inc said on Wednesday that they expect the immunity induced by the COVID-19 vaccine to be protective against the coronavirus variants reported in the UK.
The company said it plans to run tests to confirm the vaccine’s activity against any strain.
Modern comments came amid the British government’s plan to place large parts of England under its strictest COVID-19 restrictions, as a highly contagious virus variant sweeps the country.
The company said it expects its vaccine, which was recently granted US authorization for emergency use, to be protective against the UK variant based on data to date.
“We have already tested sera from animals and humans vaccinated with the Moderna COVID-19 vaccine against a number of previous variants of the SARS-CoV-2 virus that have emerged since the first outbreak of the pandemic, and continued to find our vaccine just as effective “said Moderna. (bit.ly/3pi3kqi)
The US company said it would conduct further testing of the vaccine in the coming weeks to confirm its expectation.
Reporting by Manojna Maddipatla in Bengaluru; Editing by Maju Samuel